Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Repare Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-09
Sale
2022-12-13
4:18 pm
Repare Therapeutics Inc.RPTXJerel Davis
Director
250,000$16$4,000,0003,315,739
(Indirect
Direct)
View
2022-06-13
Purchase
2022-06-15
6:15 pm
Repare Therapeutics Inc.RPTXBVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
149,161$12.73$1,898,820412,604
(Direct)
View
2022-06-03
Sale
2022-06-07
4:37 pm
Repare Therapeutics Inc.RPTXVersant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
750,000$12.25$9,188,7751,233,615
(Indirect
Direct)
View
2022-06-03
Sale
2022-06-07
4:36 pm
Repare Therapeutics Inc.RPTXVersant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
750,000$12.25$9,188,7751,233,615
(Indirect
Direct)
View
2022-06-03
Sale
2022-06-07
4:32 pm
Repare Therapeutics Inc.RPTXJerel Davis
Director
10% Owner
750,000$12.25$9,188,7751,263,593
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
6:14 pm
Repare Therapeutics Inc.RPTXBVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
1,836,958$11.9$21,859,329406,436
(Direct)
View
2022-05-18
Purchase
2022-05-20
6:09 pm
Repare Therapeutics Inc.RPTXBVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
420,000$8.5$3,570,000313,357
(Direct)
View
2022-03-15
Sale
2022-03-16
4:04 pm
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
533$11.3$6,02346,041
(Direct)
View
2022-01-19
Purchase
2022-01-21
5:12 pm
Repare Therapeutics Inc.RPTXBVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
997,961$14.1$14,071,250307,627
(Direct)
View
2021-11-16
Purchase
2021-11-18
5:00 pm
Repare Therapeutics Inc.RPTXCivik Thomas
Director
7,500$28.08$210,6007,500
(Direct)
View
2021-11-15
Sale
2021-11-17
7:46 pm
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
20,000$27.33$546,613533
(Direct)
View
2021-09-03
Sale
2021-09-08
6:29 pm
Repare Therapeutics Inc.RPTXBonita David P
Director
8,084$33.99$274,79496,190
(Indirect)
View
2021-09-03
Sale
2021-09-08
6:18 pm
Repare Therapeutics Inc.RPTXORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
8,084$33.99$274,79496,190
(Indirect)
View
2021-08-31
Sale
2021-09-02
8:27 pm
Repare Therapeutics Inc.RPTXORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
37,864$34.08$1,290,55096,428
(Indirect)
View
2021-08-31
Sale
2021-09-02
8:20 pm
Repare Therapeutics Inc.RPTXBonita David P
Director
37,864$34.08$1,290,55096,428
(Indirect)
View
2021-08-26
Sale
2021-08-30
6:37 pm
Repare Therapeutics Inc.RPTXORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
18,073$34.07$615,74897,542
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-30
Option Award
2023-02-01
9:46 pm
N/A
2033-01-29
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Scientific Officer
121,650$0167,691
(Direct)
View
2023-01-30
Option Award
2023-02-01
9:45 pm
N/A
2033-01-29
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
145,700$0295,213
(Direct)
View
2023-01-30
Option Award
2023-02-01
9:44 pm
N/A
2033-01-29
Repare Therapeutics Inc.RPTXSegal Lloyd Mitchell
President and CEO
422,750$0523,343
(Direct)
View
2023-01-30
Option Award
2023-02-01
9:44 pm
N/A
2033-01-29
Repare Therapeutics Inc.RPTXForte Steve
EVP, Chief Financial Officer
135,580$0141,737
(Direct)
View
2022-12-29
Other
2023-01-03
4:38 pm
N/A
N/A
Repare Therapeutics Inc.RPTXJerel Davis
Director
468,099$02,823,613
(Indirect)
View
2022-12-20
Exercise
2022-12-20
8:05 pm
N/A
N/A
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
51$2.425305,179
(Direct)
View
2022-12-20
Exercise
2022-12-20
8:05 pm
N/A
2029-05-01
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
48,507$0305,179
(Direct)
View
2022-12-20
Exercise
2022-12-20
8:05 pm
N/A
N/A
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
48,456$2.062305,179
(Direct)
View
2022-06-06
Other
2022-06-07
4:37 pm
N/A
N/A
Repare Therapeutics Inc.RPTXVersant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
992,305$01,233,615
(Indirect)
View
2022-06-06
Other
2022-06-07
4:36 pm
N/A
N/A
Repare Therapeutics Inc.RPTXVersant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
992,305$01,233,615
(Indirect)
View
2022-06-06
Other
2022-06-07
4:32 pm
N/A
N/A
Repare Therapeutics Inc.RPTXJerel Davis
Director
10% Owner
1,001,406$01,263,593
(Indirect)
View
2022-05-13
Option Award
2022-05-16
7:31 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXSCHAFER CAROL
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:30 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXCivik Thomas
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:29 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXRHOADS ANN D
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:27 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXFoley Todd
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:26 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXJerel Davis
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:25 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXMorrison Briggs
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:24 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXKulkarni Samarth
Director
49,000$049,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:23 pm
N/A
2032-05-13
Repare Therapeutics Inc.RPTXBonita David P
Director
49,000$049,000
(Direct)
View
2022-01-21
Exercise(A)
2022-01-24
4:55 pm
N/A
2032-01-20
Repare Therapeutics Inc.RPTXSegal Lloyd Mitchell
President and CEO
300,000$0300,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:45 pm
N/A
2032-01-17
Repare Therapeutics Inc.RPTXForte Steve
EVP, Chief Financial Officer
100,000$0100,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:43 pm
N/A
2032-01-17
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
115,000$0115,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:42 pm
N/A
2032-01-17
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
115,000$0115,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:40 pm
N/A
2032-01-17
Repare Therapeutics Inc.RPTXSegal Lloyd Mitchell
President and CEO
300,000$0300,000
(Direct)
View
2021-12-10
Exercise
2021-12-10
4:43 pm
N/A
N/A
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
51$2.425305,179
(Direct)
View
2021-12-10
Exercise
2021-12-10
4:43 pm
N/A
2029-05-01
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
48,511$0305,179
(Direct)
View
2021-12-10
Exercise
2021-12-10
4:43 pm
N/A
N/A
Repare Therapeutics Inc.RPTXKoehler Maria
EVP, Chief Medical Officer
48,460$2.062305,179
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
N/A
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
10,473$2.425219,827
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
N/A
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
15,978$1.637219,827
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
2027-06-14
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
46,041$0219,827
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
N/A
Repare Therapeutics Inc.RPTXZinda Michael
EVP, Chief Science Officer
19,590$2.062219,827
(Direct)
View

Ownership
2021-11-08
6:12 pm
N/A
N/A
Repare Therapeutics Inc.RPTXBVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
0$04,751,853
(Direct)
View
2021-09-07
Option Award
2021-09-09
5:06 pm
N/A
2031-09-07
Repare Therapeutics Inc.RPTXCivik Thomas
Director
42,000$042,000
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, Next